CAMP4 THERAPEUTICS CORP (CAMP:NASDAQ)
$4.26 -0.25 (-5.5432%)
Analysed CAMP4 THERAPEUTICS CORP (CAMP:NASDAQ) News Sources
Biotech Stock Still Up 700% Despite 30% Drop This Year as One Fund Discloses $9 Million Exit
18-03-2026
fool.com
Biotech Stock Jumps 288% Amid Massive Raise as One Early Backer Reports $14 Million Exit
18-03-2026
fool.com
CAMP4 Appoints Michael MacLean to its Board of Directors
24-03-2026
yahoo.com
CAMP4 Therapeutics Unveils Gene-Upregulation ASO Platform, Targets SYNGAP1 Clinic Entry in 2H
13-04-2026
marketbeat.com
CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
17-04-2026
yahoo.com
CAMP4 Therapeutics Preprints Pioneering Study on Regulatory RNA Profiling and Gene Upregulation
28-04-2026
yahoo.com
CAMP4 Reports First Quarter 2026 Financial Results and Corporate Highlights
07-05-2026
yahoo.com
CAMP4 Therapeutics Corporation (CAMP) Reports Q1 Loss, Lags Revenue Estimates
07-05-2026
yahoo.com
CAMP4 Therapeutics to Present New Preclinical Data Demonstrating CMP-002 Improves Seizure Threshold and Severity in a Model of SYNGAP1-Related Disorder
14-05-2026
yahoo.com
CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
21-05-2026
yahoo.com
What is the current price of CAMP4 THERAPEUTICS CORP (CAMP:NASDAQ)?
The current price of CAMP4 THERAPEUTICS CORP (CAMP:NASDAQ) is $4.26.
CAMP4 THERAPEUTICS CORP (CAMP:NASDAQ) absolute price change since previous trading day?
The absolute price change of CAMP4 THERAPEUTICS CORP (CAMP:NASDAQ) since the previous trading day is $-0.25.
CAMP4 THERAPEUTICS CORP (CAMP:NASDAQ) percentage price change since previous trading day?
The percentage price change of CAMP4 THERAPEUTICS CORP (CAMP:NASDAQ) since the previous trading day is -5.5432%.
What is the most recent average sentiment score for CAMP4 THERAPEUTICS CORP (CAMP:NASDAQ)?
The most recent average sentiment score for CAMP4 THERAPEUTICS CORP (CAMP:NASDAQ) is 77 out of 100.
What is the most recent average sentiment for CAMP4 THERAPEUTICS CORP (CAMP:NASDAQ)?
The most recent sentiment for CAMP4 THERAPEUTICS CORP (CAMP:NASDAQ) is .
SEC-8K** Filing Available For CAMP4 THERAPEUTICS CORP (CAMP:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.